Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Intravitreal Bevacizumab for the Improvement of Severe Non-proliferative Diabetic Retinopathy Without DME: a Randomized Clinical Trial
Conditions
Interventions
Intravitreal Bevacizumab IVB
Follow-up with regular examination for determination of DR progression
Start Date
September 1, 2020
Primary Completion Date
January 1, 2021
Completion Date
November 1, 2021
Last Updated
August 13, 2020
NCT06951087
NCT05393284
NCT07236645
NCT07230184
NCT06487845
NCT01853072
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions